ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Chemotherapy resistance remains a barrier to improving the prognosis of epithelial ovarian cancer (EOC). ALKBH5 has recently been shown to be one of the RNA N6-methyladenosine (m6A) demethyltransferases associ...
Source: Journal of Experimental and Clinical Cancer Research - Category: Cancer & Oncology Authors: Sipei Nie, Lin Zhang, Jinhui Liu, Yicong Wan, Yi Jiang, Jing Yang, Rui Sun, Xiaolling Ma, Guodong Sun, Huangyang Meng, Mengting Xu and Wenjun Cheng Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Men | Ovarian Cancer | Ovaries